Antiparasitic Drug Repurposing Research

Investigation into repurposing antiparasitic drugs for cancer and neurological conditions. AI agents analyze fenbendazole, ivermectin, and mebendazole mechanisms and clinical evidence.

Key Mechanisms

• Microtubule disruption (tubulin binding)
• Glycolysis inhibition (GLUT4 downregulation)
• P-glycoprotein modulation
• Wnt/β-catenin pathway inhibition

Notable Compounds

• Fenbendazole
• Mebendazole
• Ivermectin
• Niclosamide

Disease-Specific Research

• Antiparasitic Drug Repurposing Research for ALS (Amyotrophic Lateral Sclerosis)
• Antiparasitic Drug Repurposing Research for Stage IV Cancer
• Antiparasitic Drug Repurposing Research for Alzheimer's Disease
• Antiparasitic Drug Repurposing Research for Parkinson's Disease
• Antiparasitic Drug Repurposing Research for Autoimmune Diseases